Literature DB >> 19398503

Molecular basis for reduced estrone sulfate transport and altered modulator sensitivity of transmembrane helix (TM) 6 and TM17 mutants of multidrug resistance protein 1 (ABCC1).

Kazuma Maeno1, Akio Nakajima, Gwenaëlle Conseil, Alice Rothnie, Roger G Deeley, Susan P C Cole.   

Abstract

Multidrug resistance protein 1 (MRP1) confers drug resistance and also mediates cellular efflux of many organic anions. MRP1 also transports glutathione (GSH); furthermore, this tripeptide stimulates transport of several substrates, including estrone 3-sulfate. We have previously shown that mutations of Lys(332) in transmembrane helix (TM) 6 and Trp(1246) in TM17 cause different substrate-selective losses in MRP1 transport activity. Here we have extended our characterization of mutants K332L and W1246C to further define the different roles these two residues play in determining the substrate and inhibitor specificity of MRP1. Thus, we have shown that TM17-Trp(1246) is crucial for conferring drug resistance and for binding and transport of methotrexate, estradiol glucuronide, and estrone 3-sulfate, as well as for binding of the tricyclic isoxazole inhibitor N-[3-(9-chloro-3-methyl-4-oxo-4H-isoxazolo-[4,3-c]quinolin-5-yl)-cyclohexylmethyl]-benzamide (LY465803). In contrast, TM6-Lys(332) is important for enabling GSH and GSH-containing compounds to serve as substrates (e.g., leukotriene C(4)) or modulators (e.g., S-decyl-GSH, GSH disulfide) of MRP1 and, further, for enabling GSH (or S-methyl-GSH) to enhance the transport of estrone 3-sulfate and increase the inhibitory potency of LY465803. On the other hand, both mutants are as sensitive as wild-type MRP1 to the non-GSH-containing inhibitors (E)-3-[[[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]-propanoic acid (MK571), 1-[2-hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)butoxy]phenyl]-ethanone (LY171883), and highly potent 6-[4'-carboxyphenylthio]-5[S]-hydroxy-7[E], 11[Z]14[Z]-eicosatetrenoic acid (BAY u9773). Finally, the differing abilities of the cysteinyl leukotriene derivatives leukotriene C(4), D(4), and F(4) to inhibit estradiol glucuronide transport by wild-type and K332L mutant MRP1 provide further evidence that TM6-Lys(332) is involved in the recognition of the gamma-Glu portion of substrates and modulators containing GSH or GSH-like moieties.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19398503     DOI: 10.1124/dmd.109.026633

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  11 in total

Review 1.  Transport in technicolor: mapping ATP-binding cassette transporters in sea urchin embryos.

Authors:  Tufan Gökirmak; Lauren E Shipp; Joseph P Campanale; Sascha C T Nicklisch; Amro Hamdoun
Journal:  Mol Reprod Dev       Date:  2014-08-22       Impact factor: 2.609

2.  Mutation of Glu521 or Glu535 in cytoplasmic loop 5 causes differential misfolding in multiple domains of multidrug and organic anion transporter MRP1 (ABCC1).

Authors:  Surtaj H Iram; Susan P C Cole
Journal:  J Biol Chem       Date:  2012-01-09       Impact factor: 5.157

3.  Use of PET Imaging to Assess the Efficacy of Thiethylperazine to Stimulate Cerebral MRP1 Transport Activity in Wild-Type and APP/PS1-21 Mice.

Authors:  Michael Wölfl-Duchek; Severin Mairinger; Irene Hernández-Lozano; Thomas Filip; Viktoria Zoufal; Mathilde Löbsch; Johann Stanek; Claudia Kuntner; Thomas Wanek; Martin Bauer; Jens Pahnke; Oliver Langer
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

4.  Specific MRP4 Inhibitor Ceefourin-1 Enhances Apoptosis Induced by 6-Mercaptopurine in Jurkat Leukemic Cells, but Not in Normal Lymphoblast Cell Line CRL-1991.

Authors:  Edgardo Becerra; Laura Berumen; Valeria Soto-Ontiveros; Guadalupe García-Alcocer
Journal:  Medicina (Kaunas)       Date:  2022-05-24       Impact factor: 2.948

5.  Chalcogenopyrylium dyes as differential modulators of organic anion transport by multidrug resistance protein 1 (MRP1), MRP2, and MRP4.

Authors:  Robert L Myette; Gwenaëlle Conseil; Sean P Ebert; Bryan Wetzel; Michael R Detty; Susan P C Cole
Journal:  Drug Metab Dispos       Date:  2013-03-25       Impact factor: 3.922

6.  Small nucleolar RNA-derived microRNA hsa-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1.

Authors:  Yu-Zhuo Pan; Amy Zhou; Zihua Hu; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2013-05-16       Impact factor: 3.922

Review 7.  Multidrug resistance protein 1 (MRP1, ABCC1), a "multitasking" ATP-binding cassette (ABC) transporter.

Authors:  Susan P C Cole
Journal:  J Biol Chem       Date:  2014-10-03       Impact factor: 5.157

8.  A Genome-wide Haploid Genetic Screen Identifies Regulators of Glutathione Abundance and Ferroptosis Sensitivity.

Authors:  Jennifer Yinuo Cao; Aunoy Poddar; Leslie Magtanong; Jennifer H Lumb; Trevor R Mileur; Michael A Reid; Cole M Dovey; Jin Wang; Jason W Locasale; Everett Stone; Susan P C Cole; Jan E Carette; Scott J Dixon
Journal:  Cell Rep       Date:  2019-02-05       Impact factor: 9.423

9.  Conserved amino acids in the region connecting membrane spanning domain 1 to nucleotide binding domain 1 are essential for expression of the MRP1 (ABCC1) transporter.

Authors:  Emma E Smith; Gwenaëlle Conseil; Susan P C Cole
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

10.  Mutagenic Analysis of the Putative ABCC6 Substrate-Binding Cavity Using a New Homology Model.

Authors:  Flora Szeri; Valentina Corradi; Fatemeh Niaziorimi; Sylvia Donnelly; Gwenaëlle Conseil; Susan P C Cole; D Peter Tieleman; Koen van de Wetering
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.